MoonLake Immunotherapeutics (MLTX) Tax Rate (2021 - 2026)

MoonLake Immunotherapeutics' Tax Rate history runs 6 years deep, the most recent figure standing at 0.9% for Q1 2026.

• On a quarterly basis, Tax Rate fell 52.0% year-over-year to 0.9% in Q1 2026; TTM through Mar 2026 was 0.42%, a 17.0% decrease from a year earlier, with the FY2025 full-year figure at 0.27%, down 3.0% from the prior year.
• Tax Rate retreated to 0.9% in Q1 2026 per MLTX's latest filing, from 0.4% in the prior quarter.
• Across five years, Tax Rate topped out at 0.05% in Q1 2022 and bottomed at 0.9% in Q1 2026.
• The 5-year median for Tax Rate is 0.17% (2025), against an average of 0.26%.
• Across the five-year window, Tax Rate jumped 47 bps in 2024 and slumped 52 bps in 2026, its largest moves.
• Year by year, Tax Rate stood at 0.07% in 2022, then tumbled by 737 bps to 0.56% in 2023, then jumped by 84 bps to 0.09% in 2024, then slumped by 347 bps to 0.4% in 2025, then slumped by 128 bps to 0.9% in 2026.
• Per Business Quant, the three latest MLTX Tax Rate figures stand at 0.9% (Q1 2026), 0.4% (Q4 2025), and 0.16% (Q3 2025).